Reference is made to the Company’s announcements dated 23 February 2021, 25 February 2021 and 2 March 2021 pertaining to the letter of intent (“LOI”) awarded by MTPS to Metronic Medicare, a wholly-owned subsidiary of the Company.

Further to the queries raised by Bursa Malaysia Securities Berhad, the Board of Directors of Metronic wishes to announce the following additional information in relation to the LOI:-

1. The 152 million test kit was derived based on the production allocation for a period of 2 years from the manufacturer, which representing 2% of the current world population of 7.8 billion.

2. The Company is currently in the midst of negotiation with the party for the definitive agreement subsequent to the LOI and the Company predicted the definitive agreement to be made within 2 years. The relevant announcement(s) will be made upon finalising the definitive agreement.

3. The first initial payment of USD1 million has been made on 2 March 2021.

This announcement is dated 12 March 2021.